Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007

Urology
Isabelle MeiersDavid Bostwick

Abstract

Prostate cancer is a leading malignancy among men. Early prostate cancer is most commonly treated with radical surgery and radiotherapy. In the era of prostate-specific antigen and newly emerging highly specific screening tests, a greater number of men are given a diagnosis earlier in life, and disease is more often confined. Less-invasive treatments, such as focal therapy, are becoming increasingly popular, yielding shorter hospital stays, faster recovery, and fewer complications. Potential drawbacks to focal therapy include the risk of incomplete treatment, which may result from missed cancer foci and inadequate ablation to target tissues. Furthermore, this approach is not universally applicable to all patients--for example, those who have periurethral and extraprostatic extension of the tumor may not benefit from focal treatment. This article reviews the importance of multifocal prostate cancer and the application of focal treatment.

References

Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Feb 2, 1994·JAMA : the Journal of the American Medical Association·J I EpsteinC B Brendler
Jul 1, 1994·Cancer·J E Montie
Apr 27, 1999·JAMA : the Journal of the American Medical Association·T A StameyI M Johnstone
Feb 8, 2002·The Journal of Urology·H Ballentine CarterJonathan I Epstein
Jun 14, 2003·Prostate Cancer and Prostatic Diseases·S Y SongH Y Choi
Jan 27, 2004·The Prostate·Wolfgang HorningerG Bartsch
Jul 13, 2004·The Journal of Urology·Eiji KikuchiMakoto Ohori
Nov 13, 2004·The Journal of Urology·James C NgLiang Cheng
Feb 1, 2005·BJU International·Al Barqawi, E David Crawford
Apr 12, 2005·The Journal of Urology·Saadettin Yilmaz EskicorapciHaluk Ozen
Apr 15, 2005·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideaki MiyakeHiroshi Eto
Apr 30, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Liang ChengMichael O Koch
Jan 13, 2006·Prostate Cancer and Prostatic Diseases·V BhatnagarR M Kaplan
Jul 25, 2006·Hematology/oncology Clinics of North America·Robert L GrubbAdam S Kibel
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Feb 12, 2010·Future Oncology·Hashim U Ahmed, Mark Emberton
Mar 15, 2014·Current Opinion in Urology·Niccolò M Passoni, Thomas J Polascik
Dec 9, 2014·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Alena BurdovaZdenek Kolar
Apr 24, 2009·BMC Urology·Ryan Turpen, Charles J Rosser
Feb 7, 2009·Current Opinion in Urology·Judd W MoulThomas J Polascik
Feb 4, 2009·Current Opinion in Urology·Vladimir Mouraviev, John F Madden
Feb 4, 2009·Current Opinion in Urology·Thomas J PolascikVladimir Mouraviev
Apr 4, 2009·Current Opinion in Urology·Gautam Jayram, Scott E Eggener
Nov 24, 2011·Prostate Cancer·Luigi Mearini, Massimo Porena
Apr 7, 2010·Journal of Endourology·Stavros Gravas, Theo de Reijke
Apr 7, 2010·Journal of Endourology·Christian G Chaussy, Stefan Thüroff
May 7, 2010·Journal of Endourology·Vladimir MouravievThomas J Polascik
Jul 12, 2012·International Journal of Computer Assisted Radiology and Surgery·Anjali SehrawatYoed Rabin
Jul 17, 2012·Urologic Oncology·G BozziniN Betrouni
Jun 5, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J LillazF Kleinclauss
May 5, 2009·European Urology·Scott A TomlinsJack A Schalken
Sep 2, 2011·The Prostate·Viacheslav IremashviliMark S Soloway
Jun 14, 2014·Journal of Magnetic Resonance Imaging : JMRI·Adam J JungFergus V Coakley
Apr 1, 2015·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Arya AminiDavid Raben
Jan 11, 2014·European Urology·Luke DixonBenjamin Challacombe
May 5, 2016·Der Urologe. Ausg. A·M ApfelbeckC Gratzke
Jun 28, 2011·AJR. American Journal of Roentgenology·Andrew B RosenkrantzSamir S Taneja
Sep 22, 2012·AJR. American Journal of Roentgenology·Joyce G R BomersJurgen J Fütterer
Aug 25, 2010·International Journal of Surgical Pathology·Sonal GroverAshutosh K Tewari
Dec 3, 2013·Therapeutic Advances in Urology·John F Ward, Louis L Pisters
Jun 6, 2013·International Journal of Molecular Sciences·Chinyere IbeawuchiAxel Semjonow
Apr 9, 2009·Nature Reviews. Urology·Vladimir MouravievThomas J Polascik
May 2, 2018·Cold Spring Harbor Perspectives in Medicine·Mark A Rubin, Francesca Demichelis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.